Utilization of evidence-based therapy for the secondary prevention of acute coronary syndromes in Australian practice

Blackwell Publishing
Publication Type:
Journal Article
Journal Of Clinical Pharmacy And Therapeutics, 2008, 33 (6), pp. 591 - 601
Issue Date:
Full metadata record
Files in This Item:
Filename Description Size
Thumbnail2010004320OK.pdf132.44 kB
Adobe PDF
Aim: To review and document the current utilization of pharmacotherapy for the secondary prevention of acute coronary syndromes (ACS) in patients discharged from an Australian hospital. Methods: A retrospective cross-sectional study was conducted at a major Sydney teaching hospital. Patients with either a primary or secondary diagnosis of acute coronary syndrome were identified from medical records over a 4-month period (JanuaryApril 2007). A range of clinical data was extracted from medical records, including medical history, clinical presentation and pharmacotherapy both on admission and at discharge. This audit focussed on the use of four guideline-recommended therapies: aspirin ± clopidogrel, beta blockers, statins and ACEinhibitors (ACE-I), as well as the utilization of multiple antithrombotics.
Please use this identifier to cite or link to this item: